top of page

CHO-K1/Mouse VPAC1 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0230B

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)



Product Description


The VPAC1 receptor (vasoactive intestinal peptide receptor 1) is a class B G protein-coupled receptor encoded by the VIPR1 gene, binding with high affinity to both vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. It is widely distributed in multiple human tissues including the lungs, liver, intestine, pancreatic ductal epithelium, heart, kidneys, as well as lymphocytes and monocytes. Its core function involves activating Gs proteins to stimulate cAMP production, thereby mediating smooth muscle relaxation (e.g., vascular, bronchial, gastrointestinal), promoting glandular secretion, regulating immune and inflammatory responses, and playing roles in cell proliferation and survival. This receptor holds potential therapeutic value in conditions such as asthma, inflammatory bowel disease, and certain cancers.

 

Screeningbio’s CHO-K1/Mouse VPAC1 cell line overexpress VIPR1 and is designed to detect increases in intracellular cAMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Mouse

HGNC Symbol

VIPR1

Accession Number

NM_011703 (Mm)

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data

CHO-K1/Mouse VPAC1 Agonist Assay. CHO-K1/Mouse VPAC1 cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
CHO-K1/Mouse VPAC1 Agonist Assay. CHO-K1/Mouse VPAC1 cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.


Target Background


The VPAC1 receptor (vasoactive intestinal peptide receptor 1) is a class B G protein-coupled receptor encoded by the VIPR1 gene, binding with high affinity to both vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.


It is widely distributed in multiple human tissues including the lungs, liver, intestine, pancreatic ductal epithelium, heart, kidneys, as well as lymphocytes and monocytes. Its core function involves activating Gs proteins to stimulate cAMP production, thereby mediating smooth muscle relaxation (e.g., vascular, bronchial, gastrointestinal), promoting glandular secretion, regulating immune and inflammatory responses, and playing roles in cell proliferation and survival.


This receptor holds potential therapeutic value in conditions such as asthma, inflammatory bowel disease, and certain cancers.

Product Documentation



bottom of page